You are here

  • Home
  • Archive
  • Volume 11, Issue 8
  • Correction: Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1

https://doi.org/10.1136/jitc-2023-007114corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Sugiyarto G, Lau D, Hill SL, et al. Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1. Journal for ImmunoTherapy of Cancer 2023;11:e007114. doi: 10.1136/jitc-2023-007114

    The author Tim Elliott has been made a corresponding author and Eileen E Parkes was incorrectly listed as Eileen Parkes. The third affiliation has been updated to Department of Oncology, University of Oxford, Oxford, UK.